Assembly Biosciences Company Profile (NASDAQ:ASMB)

Analyst Ratings

Consensus Ratings for Assembly Biosciences (NASDAQ:ASMB) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Assembly Biosciences (NASDAQ:ASMB)
Show:
DateFirmActionRatingPrice TargetActions
3/18/2015Cantor FitzgeraldReiterated RatingHold$6.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/29/2014 forward)

Earnings

Earnings History for Assembly Biosciences (NASDAQ:ASMB)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
11/21/2014($0.49)($1.33)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/2/2014($0.28)($0.29)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Assembly Biosciences (NASDAQ:ASMB)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Assembly Biosciences (NASDAQ:ASMB)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Assembly Biosciences (NASDAQ:ASMB)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
2/11/2016Derek A. SmallCEOBuy10,000$5.53$55,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/27/2014Russell H EllisonCEOBuy13,000$0.92$11,960.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/23/2014David Jonathan BarrettCFOBuy6,980$0.86$6,002.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/23/2014Russell H EllisonCEOBuy20,000$0.91$18,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/21/2014Russell EllisonCEOBuy10,000$0.87$8,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2014David Jonathan BarrettCFOBuy40,000$0.88$35,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/5/2013Russell H EllisonCEOBuy15,000$2.55$38,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Assembly Biosciences (NASDAQ:ASMB)
DateHeadline
07/07/16 02:36 PMTraders Are Bearish Assembly Biosciences Inc After The Stock Formed Multiple Bottom Chart Pattern - Press Telegraph
07/04/16 02:33 PMAssembly Biosciences Incorporated (NASDAQ:ASMB) Shorted Shares Decreased By 7.05% - Engelwood Daily
07/04/16 07:27 AMREVIEW: Top Gainers, Losers in Manufacturing Sector
06/30/16 10:28 AMDrug Most Volatile Stocks: Echo Therapeutics (NASDAQ:ECTE), Biostar Pharmaceuticals (NASDAQ:BSPM), Assembly ... - KC Register
06/28/16 02:49 PMTraders Are Bearish Assembly Biosciences Inc After The Stock Formed Bearish Multiple Bottom - Press Telegraph
06/08/16 05:04 PMAssembly Biosciences, Inc. :ASMB-US: Earnings Analysis: Q1, 2016 By the Numbers : June 8, 2016 -
06/07/16 10:31 AMHealthcare Stocks in Focus: Tonix (NASDAQ:TNXP), Echo Therapeutics, (NASDAQ:ECTE), Assembly Biosciences ... - KC Register
06/06/16 03:02 PMASSEMBLY BIOSCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a -
06/01/16 08:43 PMGaps Down Stocks - ASMB, KRNT, NSIT, WSCI, LE, APHB, DAKT - FxPips.com - Gaps Down Stocks - ASMB, KRNT, NSIT, WSCI, LE, APHB, DAKTFxPips.comAssembly Biosciences Inc. (ASMB) had a gap down of (0.445) pts or -7.79 pct below its previous close of $5.71. The company traded at $5.61 – 0.10 (1.75 pct). Kornit Digital Ltd. (KRNT) had a gap down of (1.1299) pts or -11.48 pct below its previous ...
06/01/16 02:39 PMAssembly Biosciences to Present at the Jefferies 2016 Global Healthcare Conference - PharmiWeb.com (press release) - Assembly Biosciences to Present at the Jefferies 2016 Global Healthcare ConferencePharmiWeb.com (press release)NEW YORK, June 01, 2016 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel oral biological therapeutics ...and more »
06/01/16 06:43 AMAssembly Biosciences to Present at the Jefferies 2016 Global Healthcare Conference - [at noodls] - NEW YORK, June 01, 2016 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection ...
05/28/16 12:40 PMAssembly Biosciences Inc Stock Faces Higher Risks Forward After Forming Bearish Multiple Bottom - HNN - Assembly Biosciences Inc Stock Faces Higher Risks Forward After Forming Bearish Multiple BottomHNNThe stock of Assembly Biosciences Inc (ASMB) shows a multiple bottoms pattern with $4.84 target or 10.00% below today's $5.38 share price. The 8 months chart pattern indicates high risk for the $90.03 million company. It was reported on May, 28 by ...
05/27/16 01:40 PMAssembly Biosciences Incorporated (NASDAQ:ASMB) Sellers Increased By 9.31% Their Shorts - Wall Street Hints and News - Assembly Biosciences Incorporated (NASDAQ:ASMB) Sellers Increased By 9.31% Their ShortsWall Street Hints and NewsThe short interest to Assembly Biosciences Incorporated's float is 8.98%. The stock is down 0.37% or $0.02 after the news, hitting $5.43 per share. Assembly Biosciences Inc (NASDAQ:ASMB) has declined 42.51% since October 21, 2015 and is downtrending.and more »
05/26/16 12:44 PMGaps Up Stocks Daily Roundup - PRTO, FMD, ASMB, OCC, MARA, GASS, AGLE - FxPips.com - Gaps Up Stocks Daily Roundup - PRTO, FMD, ASMB, OCC, MARA, GASS, AGLEFxPips.comAssembly Biosciences Inc (ASMB) had a gap up of 0.05 pts or 0.98 pct above its previous close of $5.09. The company traded at $5.14 + 0.05 (0.98 pct). Optical Cable Corp. (OCC) had a gap up of 0.23 pts or 9.66 pct above its previous close of $2.38.
04/13/16 06:22 AMAssembly Biosciences to Present Data at The International Liver Congress(TM) 2016 that Supports Advancing Its CpAM Candidates into HBV Clinical Trials - [at noodls] - -In Preclinical Studies, Novel Class of Core Protein Allosteric Modifiers (CpAMs) Showed Potent Antiviral Activity, No Cytotoxicity and Good Pharmacokinetic Properties- -Planning to Start Phase 1 Trials ...
03/30/16 06:50 AMAssembly Biosciences to Present Data on New Series of HBV Core Protein Allosteric Modifiers at The International Liver Congress™ 2016 - [at noodls] - BARCELONA, Spain and NEW YORK, March 30, 2016 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a public biotechnology company advancing a new class of oral biologic therapeutics for addressing ...
03/11/16 03:04 PMASSEMBLY BIOSCIENCES, INC. Files SEC form 10-K, Annual Report -
02/28/16 01:54 PMAssembly Biosciences Incorporated (NASDAQ:ASMB) Shorted Shares Increased By 8.41% - RiversideGazette.com - Assembly Biosciences Incorporated (NASDAQ:ASMB) Shorted Shares Increased By 8.41%RiversideGazette.comThe short interest to Assembly Biosciences Incorporated's float is 7.06%. The stock increased 0.81% or $0.04 on February 26, hitting $4.95. About 54,707 shares traded hands or 18.44% up from the average. Assembly Biosciences Inc (NASDAQ:ASMB) has ...and more »
02/19/16 01:59 PMAssembly Biosciences Incorporated (NASDAQ:ASMB) Shorted Shares Increased 1.18% After Market Selling - Franklin Independent - Assembly Biosciences Incorporated (NASDAQ:ASMB) Shorted Shares Increased 1.18% After Market SellingFranklin IndependentThe short interest to Assembly Biosciences Incorporated's float is 6.28%. The stock is down 1.03% or $0.06 after the news, hitting $5.74 per share. About 2,850 shares traded hands. Assembly Biosciences Inc (NASDAQ:ASMB) has declined 67.67% since July ...and more »
02/19/16 01:59 PMAssembly Biosciences to Webcast Upcoming Investor Conferences - GlobeNewswire (press release) - Assembly Biosciences to Webcast Upcoming Investor ConferencesGlobeNewswire (press release)INDIANAPOLIS, Feb. 19, 2016 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a public biotechnology company advancing a new class of oral biologic drugs for addressing the gut microbiome and new approaches to discovering drugs ...
02/19/16 06:30 AMAssembly Biosciences to Webcast Upcoming Investor Conferences - [GlobeNewswire] - INDIANAPOLIS, Feb. 19, 2016-- Assembly Biosciences, Inc., a public biotechnology company advancing a new class of oral biologic drugs for addressing the gut microbiome and new approaches to discovering ...
02/18/16 01:42 PMAssembly Biosciences, Inc. (ASMB) Files Form 4 Insider Buying : Derek A Small Buys 10000 Shares - Los Angeles Mirror - Assembly Biosciences, Inc. (ASMB) Files Form 4 Insider Buying : Derek A Small Buys 10000 SharesLos Angeles MirrorAssembly Biosciences, Inc. (ASMB): Derek A Small , CEO of Assembly Biosciences, Inc. purchased 10,000 shares on Feb 10, 2016. The Insider buying transaction was disclosed on Feb 12, 2016 to the Securities and Exchange Commission in a Form-4 filing.
02/12/16 01:03 PMAssembly Biosciences Incorporated (NASDAQ:ASMB) Shorted Shares Increased By 1.18% - fdanewsalert.com - Assembly Biosciences Incorporated (NASDAQ:ASMB) Shorted Shares Increased By 1.18%fdanewsalert.comThe short interest to Assembly Biosciences Incorporated's float is 6.28%. The stock is down 0.09% or $0.01 after the news, hitting $5.49 per share. About 22,179 shares traded hands. Assembly Biosciences Inc (NASDAQ:ASMB) has declined 69.24% since ...and more »
02/11/16 12:55 PMWill Assembly Biosciences Inc Go Down Anytime Soon? - Sonoran Weekly Review - Will Assembly Biosciences Inc Go Down Anytime Soon?Sonoran Weekly ReviewThe stock of Assembly Biosciences Inc (NASDAQ:ASMB) is a huge mover today! The stock increased 11.52% or $0.57 during the last trading session, hitting $5.52. About 68,694 shares traded hands or 43.43% up from the average. Assembly Biosciences Inc ...
02/08/16 12:25 PMTrader's Recap: Travelport Worldwide Limited (NYSE:TVPT), Assembly Biosciences, Inc. (NASDAQ:ASMB), Neogen ... - KC Register - Trader's Recap: Travelport Worldwide Limited (NYSE:TVPT), Assembly Biosciences, Inc. (NASDAQ:ASMB), Neogen ...KC RegisterTravelport Worldwide Limited (NYSE:TVPT) announced that it will host its fourth quarter 2015 earnings conference call at 9:00 a.m. (Eastern Time) on Thursday, February 18, 2016. The Company's earnings results will be released prior to the market opening.
02/06/16 01:00 PMAssembly Biosciences Incorporated (NASDAQ:ASMB) Shorted Shares Increased By 19.64% - fdanewsalert.com - Assembly Biosciences Incorporated (NASDAQ:ASMB) Shorted Shares Increased By 19.64%fdanewsalert.comThe stock of Assembly Biosciences Incorporated (NASDAQ:ASMB) registered an increase of 19.64% in short interest. ASMB's total short interest was 575,700 shares in February as published by FINRA. Its up 19.64% from 481,200 shares, reported previously.and more »
02/04/16 11:54 AMWhat's in Assembly Biosciences Inc After Reaching 52-Week Low? - WallStreet.org - What's in Assembly Biosciences Inc After Reaching 52-Week Low?WallStreet.orgThe stock of Assembly Biosciences Inc (NASDAQ:ASMB) hit a new 52-week low and has $4.67 target or 10.00% below today's $5.19 share price. The 5 months bearish chart indicates high risk for the $88.20 million company. The 1-year low was reported on ...and more »
02/02/16 11:43 AMLatest Alerts: SunEdison (NYSE:SUNE), Nokia Corporation (NYSE:NOK), Assembly Biosciences (NASDAQ:ASMB ... - Property Mentor - Latest Alerts: SunEdison (NYSE:SUNE), Nokia Corporation (NYSE:NOK), Assembly Biosciences (NASDAQ:ASMB ...Property MentorOld Dominion Freight Line Inc. (NASDAQ:ODFL) shares moved up 3.36% in last trading session and ended the day at $56.67. ODFL Gross Margin is 87.30% and its has a return on assets of 12.80%. Old Dominion Freight Line Inc. (NASDAQ:ODFL) quarterly ...
02/01/16 11:25 AMCompany Shares of Assembly Biosciences, Inc. (NASDAQ:ASMB) Drops by -11.11% - Bull Report - Company Shares of Assembly Biosciences, Inc. (NASDAQ:ASMB) Drops by -11.11%Bull ReportAssembly Biosciences, Inc. (NASDAQ:ASMB) has lost 11.11% during the past week and dropped 31.82% in the last 4 weeks. The shares are however, negative as compared to the S&P 500 for the past week with a loss of 12.64%. Assembly Biosciences, Inc.Assembly Biosciences Inc (NASDAQ:ASMB) Given Average Rating of "Hold" by AnalystsEMQall 5 news articles »
01/27/16 11:01 AMAssembly Biosciences Presents Clinical Data at Drug Formulation Bioavailability Summit Showing Its Oral Gemicel(TM ... - EconoTimes - Assembly Biosciences Presents Clinical Data at Drug Formulation Bioavailability Summit Showing Its Oral Gemicel(TM ...EconoTimesPHILADELPHIA and INDIANAPOLIS, Jan. 27, 2016 -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a biotechnology company developing treatments for infectious diseases including hepatitis B virus (HBV) and C. difficile (CDI), today reported that Mohan ...and more »
01/27/16 06:54 AMAssembly Biosciences Presents Clinical Data at Drug Formulation & Bioavailability Summit Showing Its Oral Gemicel(TM) Technology Achieves Targeted Delivery to the Lower GI Tract - [at noodls] - and , (GLOBE NEWSWIRE) -- (NASDAQ:ASMB), a biotechnology company developing treatments for infectious diseases including hepatitis B virus (HBV) and C. difficile (CDI), today reported that , PhD, Assembly's ...
01/22/16 05:50 PMAssembly Biosciences, Inc. (ASMB) - 21-Dec-15 ASSEMBLY BIOSCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, F 9-Nov-15 ASSEMBLY BIOSCIENCES, INC. Files SEC form 10-Q, Quarterly Report 13-Aug-15 ASSEMBLY BIOSCIENCES, INC. Files SEC form 10 ...
01/12/16 05:04 AMASSEMBLY BIOSCIENCES, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits -
01/11/16 06:58 AMAssembly Biosciences Expands Senior Leadership Team - [at noodls] - , (GLOBE NEWSWIRE) -- (NASDAQ:ASMB), a biotechnology company developing curative treatments for infectious diseases including hepatitis B virus (HBV) and C. difficile (CDI) infections, today announced ...
12/21/15 03:40 PMASSEMBLY BIOSCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, F -
12/21/15 06:43 AMAssembly Biosciences Appoints Biotech Veteran Alan J. Lewis to Board of Directors - [at noodls] - , (GLOBE NEWSWIRE) -- (NASDAQ:ASMB), a biotechnology company developing curative treatments for infectious diseases including hepatitis B virus (HBV) and C. difficile (CDI) infections, today announced ...
12/16/15 06:35 AMAssembly Biosciences to Present at Jefferies Microbiome Summit - [at noodls] - , (GLOBE NEWSWIRE) -- (NASDAQ:ASMB), a biotechnology company developing curative treatments for infectious diseases including hepatitis B virus (HBV) and C. difficile (CDI) infections, announced that the ...
12/09/15 06:20 AMClinical Study Shows Assembly Biosciences' Oral Gemicel™ Technology Can Achieve Targeted Delivery to the Lower GI Tract for Microbiome and Other Applications - [at noodls] - Clinical Study Shows Assembly Biosciences' Oral Gemicel™ Technology Can Achieve Targeted Delivery to the Lower GI Tract for Microbiome and Other Applications
12/08/15 12:17 PMASSEMBLY BIOSCIENCES, INC. Financials -
11/09/15 03:14 PMASSEMBLY BIOSCIENCES, INC. Files SEC form 10-Q, Quarterly Report -

Social

About Assembly Biosciences

Assembly Biosciences logoAssembly Biosciences, Inc. (Assembly) is a biopharmaceutical company. The Company is engaged in the development of oral therapies for the cure of intractable infectious diseases, focusing on hepatitis B virus (HBV) and clostridium (C.) difficile-associated infections (CDAD). The target of Assembly's lead program is a clinical cure for HBV, for , which it is developing a series of compounds, known as core protein allosteric modulators (CpAMs). Assembly's clinical strategy includes testing CpAMs as monotherapy and in combination. Assembly's CDAD program is -based on the targeted delivery of microbiome-based therapies in an oral formulation, applying Assembly's coating and encapsulation technology that allows for targeted delivery of complex agents to select regions of the gastrointestinal (GI) tract. The Company's HBV and microbiome therapies are both in pre-clinical development stages.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: Pharmaceuticals
  • Exchange: NASDAQ
  • Symbol: ASMB
  • CUSIP: 92282210
Key Metrics:
  • Previous Close: $5.95
  • 50 Day Moving Average: $5.91
  • 200 Day Moving Average: $5.54
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $102.49M
  • Beta: 0.85
  • Current Year EPS Consensus Estimate: $N/A EPS
  • Next Year EPS Consensus Estimate: $N/A EPS
Additional Links:
Assembly Biosciences (NASDAQ:ASMB) Chart for Friday, July, 29, 2016